Comprehensive Sequencing Program Shows Promise of Precision Medicine for Advanced Cancer08/02/2017
The average metastatic cancer has more genetic mutations than are seen in early stage tumors, a new study finds. What that means: To make precision medicine a reality in cancer care, you need a real-time, comprehensive approach that looks at the metastatic tumors and sequences to a level of detail beyond most commercial tests.
A New Device for Rapidly Assessing Immune System Reactions06/07/2017
A multidisciplinary University of Michigan team has developed a device to quickly assess the immune response in pediatric intensive care patients.The device eventually could be used in ICUs nationwide to help treat children who have developed overwhelming sepsis, for example.
A Fish in a Pond or a Needle in a Haystack? DNA Tool Raises Promise, Privacy Concerns05/18/2017
For the first time, researchers connected two different types of DNA snippets to identify individuals. This could help researchers across many fields — but isn’t without risk.
In the Jump from Opioid-Free to Long-Term User, Surgery Plays a Key Role04/12/2017
About 6 percent of people who hadn’t been taking opioids before an operation but were prescribed the drugs to ease post surgery pain still got the drugs three to six months later, a study finds.
Maximizers vs. minimizers: The personality trait that may guide your medical decisions –and costs04/09/2017
Do certain people want more medical care than others do? And, does that matter? Research suggests medical maximizing or minimizing could explain the different ways people use health care.
Are we fighting cancer wrong?04/03/2017
Chemotherapy. Radiation. Surgery. Doctors go after the tumors that they can see. But the seeds that cause cancer to spread? Those are thought to be single cells or clusters of cells, traveling through the bloodstream. It’s hard to eradicate them with such blunt instruments.
Diabetes in your DNA? Scientists zero in on the genetic signature of risk02/13/2017
More than 80 tiny DNA differences seem to raise the risk of type 2 diabetes in some people. Now scientists havereported a discovery that might explain how multiple genetic flaws can lead to the same disease. They’ve identified something that some of those diabetes-linked genetic defects have in common: they seem to change the way certain cells in the pancreas “read” their genes.